JP6228578B2 - Drug container - Google Patents

Description

  The present invention relates to a drug container made of paper, in particular, containing a volatile drug such as an insect repellent for clothes and a fragrance.

  Conventionally, plastic and paper drug containers are known as containers for volatilizing drugs. For example, Patent Document 1 discloses a chemical volatilization body in which a carrier holding a room temperature volatile insecticide is housed in a polyethylene terephthalate resin container. In Patent Document 2, a carrier containing room temperature volatile pyrethroid is housed in a breathable paper case which is molded with paper having a volatile substance-impermeable plastic layer laminated on one side or both sides and provided with a volatile hole. Insect repellents are disclosed.

  However, the plastic drug container disclosed in Patent Document 1 requires a certain amount of thickness for molding, and has to have a relatively large shape. Furthermore, it is necessary to separate and dispose of the drug container and the carrier at the time of disposal.

Moreover, since the container main body is paper, the insect repellent disclosed in Patent Document 2 can be thinned. In addition, since the penetration of the drug into the paper is blocked by the above-mentioned impermeable plastic layer, the drug penetrates into the paper container, and so-called drug contamination that contaminates clothes, furniture, etc. in contact with the paper container. Generation can also be reduced.
However, in the insect repellent disclosed in Patent Document 2, the impermeable plastic layer is not laminated on the end surface of the paper container. Therefore, when the drug-containing carrier is in contact with the end surface of the paper container, the drug is removed from the end surface. This could cause drug contamination and was not necessarily excellent in handling.

JP 2013-39112 A JP 2003-230347 A

  An object of the present invention is to provide a drug container that greatly reduces the occurrence of drug contamination, is thin, excellent in handling, and easy to dispose of.

As a result of intensive studies to solve the above problems, the present inventors have made a structure in which the drug impregnated body does not come into contact with the end face of the paper container in which the drug penetration preventing layer is formed on the inner surface. The present inventors have found that a drug container with greatly reduced generation can be provided, and have completed the present invention. That is, the chemical | medical agent container of this invention has the following structures.
(1) a drug-impregnated body impregnated with a volatile chemical, and a paper container in which a chemical penetration preventing layer is formed on the inner surface to contain the chemical-impregnated body and an opening window for volatilization is formed, A drug container, characterized in that the drug impregnated body is provided with blocking means that can move within the paper container but does not approach the end face of the paper container.
(2) The paper container is made of a paper sheet having a drug penetration preventing layer formed on the inner surface, and the paper sheet has a top sheet part and a back sheet part that are superposed on each other in a state where the drug impregnated body is accommodated. The side portions of both sheet portions are joined to each other, and the paper container is suspended, and at least the lower end portion of one of the top sheet portion and the back sheet portion is below The drug-impregnated body formed in the paper container is formed with a protrusion at least at the lower end, and the blocking means includes a tongue of the paper sheet. The drug container according to (1), wherein the drug container is configured to be folded back so as to cover at least a tip portion of the protrusion.
(3) The paper container is made of a paper sheet having a drug permeation preventing layer formed on the inner surface, and the paper sheet has a top sheet part and a back sheet part that are overlapped with each other while containing the drug impregnated body. The side portions of both sheet portions are joined to each other and the paper container is suspended, and at least the lower end of one of the top sheet portion and the back sheet portion is at the center of the sheet portion. The concave portion is formed in a concave shape, and the tongue protrudes downward from the concave end. The blocking means has the tongue of the paper sheet at least the end of the drug-impregnated body. The drug container according to (1), which is configured to be folded back so as to overlap with each other.

  According to the drug container of the present invention, a drug penetration preventing layer is formed on the inner surface of the paper container, and the occurrence of drug contamination from the end surface of the paper container can also be prevented by the blocking means. In addition, the paper container is advantageous in that it can be made thin and can be easily disposed of.

It is an expanded view of the chemical | medical agent container which concerns on one Embodiment of this invention. FIG. 2 is a development view showing a state in which a tongue protruding from both ends of a paper container is folded in the medicine container shown in FIG. 1. It is a front view which shows the assembly state of the chemical | medical agent container which concerns on one Embodiment of this invention. FIG. 4 is a partial cross-sectional view of FIG. 3. It is a partial expanded view which shows the modification of one Embodiment of this invention shown in FIG. It is a front view which shows the use condition of the indicator function in one Embodiment of this invention. It is an expanded view of the chemical | medical agent container which concerns on other embodiment of this invention. FIG. 8 is a development view showing a state in which the tongue protruding from the concave portions at both ends of the paper container is folded back in the medicine container shown in FIG. 7. It is a fragmentary sectional view in the assembly state of the chemical | medical agent container 3 shown to FIG. 7 and FIG.

  A drug container according to an embodiment of the present invention will be described below with reference to the drawings. FIG. 1 is a development view of the drug container of the present embodiment. As shown in FIG. 1, the drug container 1 of this embodiment includes a drug-impregnated sheet 2 (drug-impregnated body) and a paper sheet 3 assembled into a paper container that accommodates the drug-impregnated sheet 2. In FIG. 1, alternate long and short dash lines indicate folding lines A1, A2, A3, and A4 during assembly.

The paper sheet 3 includes a top sheet portion 31 and a back sheet portion 32 that are continuous via a fold line A1. The top sheet portion 3 1 has has an opening window 4 the drug in the central portion is volatilized, the hanging element 5 for hanging the medicine container into the garment storage case closet like the top. Although the hanging part 5 has a ring shape, a perforation 6 for cutting is formed to hook the hanging part 5 on a pole in the clothes storage. Moreover, the indicator sheet display part 7 which displays the use start time mentioned later is formed in the surface sheet part 31 at the side part.

The back sheet part 32 has the joint part 8 on the side part via the fold line A2. The joining portion 8 serves as a so-called glue margin when joining the top sheet portion 31 and the back surface sheet portion 32. In addition, tongues 9 and 9 protrude from both end portions of the back sheet portion 32 (the upper end portion and the lower end portion when the drug container 1 is suspended) via folding lines A3 and A4, respectively. The tongue portion 9 is formed to be foldable toward the back surface sheet portion 32 along folding lines A3 and A4.
The width of the tongue portion 9 is not particularly limited and may be the same length as the width of the back sheet portion 32. However, even when the drug impregnated sheet 2 moves to the side, it is provided at both ends of the drug impregnated sheet 2. Further, it is necessary that at least the tip of projections 10 and 10 to be described later have at least a length that does not come off from the tongue 9.

The paper sheet 3 is formed with a drug permeation preventing layer on at least the inner surfaces of the top sheet portion 31 and the back sheet portion 32 that are the inner surfaces in a state of being assembled in a paper container. Examples of the chemical penetration preventing layer include thermoplastic resins such as polyethylene, polypropylene, polyester (for example, polyethylene terephthalate, polybutylene terephthalate), and polyamide.
In order to form the chemical penetration preventing layer on the paper sheet 3, for example, surface coating, extrusion coating processing, laminating processing, or the like can be used. The thickness of the drug penetration preventing layer is not particularly limited as long as the penetration of the drug can be prevented.
In general, the paper sheet 3 is formed by punching a paper sheet on which a drug penetration preventing layer is formed by Thomson processing, laser processing, or the like. Therefore, the end surface 12 of the paper sheet 3 is not formed with a drug penetration preventing layer. When the drug adheres to the end surface 12, the drug soaks into the paper sheet 3 from the end surface 12, and drug contamination occurs.

The drug impregnated sheet 2 is obtained by impregnating a volatile drug into a base material. As the base material, members conventionally used for impregnating and supporting chemicals in insect repellents and the like can be used. For example, cellulose base materials such as paper, pulp, linter, viscose, wood, ethylene- Examples thereof include plastic base materials such as vinyl acetate resins and olefin polymers, and inorganic base materials such as calcium silicate, which are formed into films, sheets, mats, and the like. The size can be variously selected according to the purpose, and supports of various materials may be used in combination.
In addition, the volatile chemicals in the present invention are not particularly limited, and examples include insect repellents, fragrances, deodorants, deodorants, fungicides, bactericides, and the like, one or more of these. May be used in combination.

  As the insect repellent, volatile chemicals used for pest control, extermination, repelling and the like can be used. Examples of the drug component of the insect repellent include organophosphorus, carbamate, pyrethroid, and amide-type insecticides, insect growth regulators, and the like. These may be used alone or in combination of two or more. it can. Specific examples of the insect repellent that can be used are shown below.

  Examples of pyrethroid insecticides include pyrethrin, allethrin, phthalthrin, resmethrin, framethrin, permethrin, phenothrin, fenvalerate, esfenvalerate, prafenthrin, tefluthrin, transfluthrin, methfluthrin, profluthrin, cypermethrin, phenprothrin. , Fenfluthrin, empentrin, terrareslin, etofenprox, imiprotorin and the like. Examples of the organophosphorus insecticide include DDVP, diazinon, fenitrothion, fenthion and the like. Examples of carbamate insecticides include propoxer and carbaryl. Furthermore, sublimable insect repellents such as paradichlorobenzene, naphthalene and camphor can be used.

  Various additives such as a commonly used pest repellent, efficacy enhancer, volatilization rate improver and the like can be arbitrarily added to these insect repellents. Pest repellents include, for example, N, N-diethyl-m-toluamide, 2,3,4,5-bisbutylene-tetrahydrofural, di-n-propylisocincomeronate, di-n-butyl succinate, 2- Examples thereof include hydroxyethyl octyl sulfide. Examples of the potentiating agent include piperonyl butoxide, N-propyl isomer, isobornyl thiocyanoacetate and the like. Examples of the volatilization rate improver include phenethyl isothiocyanate.

  Known essential oils, perfume ingredients, etc. can be used as other insect repellents, fragrances, deodorants and deodorants. For example, cypress oil, cedar oil, red cedar oil, juniper oil, asunaro oil, cypress oil, black bean oil, hiba oil, abies oil, turpentine oil, rice pine oil, cedar oil, camphor oil, mellow, sassafras oil, lemon oil , Orange oil, bergan motto oil, clove oil, eucalyptus oil, peppermint oil, almond oil, paging oil, perch oil, kayabuchi oil, citronella oil, fennel oil, garlic oil, ginger oil, grapefruit oil, lemongrass oil, nutmeg oil , Sage oil, green tea extract, jasong, dragon scent, phytoncide, turpentine, sydrene, ciderol, camphene, kazinen, camphor, cineol, menthol, judin, sabinene, hinokitiol, linalool, limonene, terpene alcohols, terpene ethers , Terpene chloride Eugenol, anethole, safrole, hinokiol, sugiol, hinoki flavone, pinene, geraniol, citronellal, borneol, benzyl alcohol, anise alcohol, aldehyde, citral, citronellal, vanillin, carvone, ketone, menthone, acetophenone, coumarin, ethyl acetate, Octyl acetate, butyl propionate, isopropyl isobutyrate, allyl caproate, methyl cinnamate, methyl salicylate, benzyl acetate, benzyl propionate, amylcinnamic aldehyde, anisic aldehyde, diphenyl oxide, methyl benzoate, ethyl benzoate, phenyl Methyl acetate, ethyl phenylacetate, neoline, safrole, lauryl methacrylate, geranyl crotonate, myris Le acid acetophenone, para-methyl acetophenone, and benzaldehyde and the like.

  Examples of fungicides and / or fungicides include triclosan, isopropylmethylphenol, 2,3,5,6-tetrachloro-4 (methylsulfonyl) pyridine, benzalkonium chloride, benzethonium chloride, hinokitiol, diclofluuride, Examples thereof include N- (fluorodichloromethylthio) -phthalimide, thiabendazole (TBZ), dioxin, cetylpyridinium chloride, isothiazoline fungicides, paraoxybenzoic acid esters such as methylparaben and ethylparaben, and parachlorometaxylenol.

  These drugs may be used singly or in combination, and the amount (concentration) to be used may be appropriately determined so as to achieve a desired effect in consideration of the kind of the drug, volatility, and the like. Moreover, you may mix | blend various stabilizers with said chemical | medical agent suitably.

  As shown in FIG. 1, the drug impregnated sheet 2 has protrusions 10 and 10 formed at both ends, and is placed on the surface of the paper sheet 3 on which the drug permeation preventing layer is formed. The The protrusions 10 and 10 have at least a tip formed in an arc shape. The protrusions 10, 10 at both ends have their tips positioned closer to the center side of the back sheet portion 32 than the fold lines A 3, A 4 of the tongues 9, 9. The drug impregnated sheet 2 is movable because it is not attached to the back sheet portion 32 with an adhesive or the like.

  Hereinafter, a method of folding the paper sheet 3 and assembling it into a paper container that houses the drug-impregnated sheet 2 will be described. From the unfolded state shown in FIG. 1, as shown in FIG. 2, the tongue portions 9, 9 of the back sheet portion 32 are folded back along the fold lines A 3, A 4 shown in FIG. The sheet is overlaid on the back sheet portion 32 so as to cover at least the tip portion.

From this state, the joining portion 8 is folded back on the back sheet portion 32 at the fold line A2 (indicated by an arrow in FIG. 2), and then the top sheet portion 31 and the back sheet portion 32 are folded at the fold line A1 (arrow in FIG. 2). ). And the back surface (back side of the paper surface of FIG. 2) of the joining portion 8 is overlapped with the region B of the top sheet portion 31 and joined by an adhesive.
Thus, as shown in FIG. 3, a drug container 1 in which the drug-impregnated sheet 2 is accommodated in a paper container 11 formed by folding the paper sheet 3 is obtained. The chemical | medical agent contained in the chemical | medical agent impregnation sheet | seat 2 is volatilized outside from the opening window 4 of the chemical | medical agent container 1. FIG.

The drug container 1 obtained in this manner is suspended from a clothes storage or the like using the suspension unit 5. In such a suspended state, as shown in FIG. 4, the tongue portion 9 at the lower end of the back surface sheet portion 32 is folded back so as to cover at least the front end portion of the protrusion portion 10 of the drug-impregnated sheet 2. The drug impregnated sheet 2 is prevented from coming into contact with the end surface 12 of the container 11. Therefore, the medicine in the medicine impregnated sheet 2 is prevented from penetrating into the paper container 11 from the end face 12 of the paper container 11, and the occurrence of chemical contamination can be greatly reduced.
Further, as shown in FIG. 4, the drug-impregnated sheet 2 is located on the back sheet portion 32 side and is separated without contacting the inner surface of the top sheet portion 31, so that an opening window provided in the top sheet portion 31. The end surface of 4 is also prevented from coming into contact with the drug-impregnated sheet 2.
In particular, since the protrusion 10 of the drug-impregnated sheet 2 has an arcuate tip, the tip of the protrusion 10 comes into point contact with the inner surface of the folded portion of the tongue 9, and the drug-impregnated sheet 2 is made of paper. Contact with the end face 12 of the container 11 can be effectively prevented.

  In the present embodiment, the tongue 9 and the protrusion 10 are also provided at the upper ends of the back sheet 32 and the drug impregnated sheet 2, respectively. This is because, for example, the medicine container 1 may be placed sideways when transporting or storing the medicine container 1, and the medicine-impregnated sheet 2 moves so that the medicine comes from the end face on the upper end side. Prevents soaking. However, it is not always necessary to form the tongue 9 and the protrusion 10 on the upper end side.

  Moreover, in this embodiment, the tongue part 9 and the protrusion part 10 were each provided in the back surface sheet part 32 and the chemical | medical agent impregnation sheet | seat 2, respectively, However, Their formation position and number are not specifically limited. For example, as shown in FIG. 5, two tongue portions 9 and two protrusion portions 10 may be provided at the same end portion.

  Next, the indicator display unit 7 formed on the paper container 11 will be described. As shown in FIG. 3, an indicator display unit 7 is formed on the side of the medicine container 1. The indicator display unit 7 is used as a guideline for the replacement timing of the medicine container. In this embodiment, numbers from January to December are printed on the surface of the medicine container 1 in the vertical direction in order on a monthly basis. ing. And the bending piece 71 protrudes to the side from the printing area of each month. A perforated line 72 that can be cut is formed between the adjacent bent pieces 71 and 71.

At the time of use, the bent piece 71 beside the moon to be used is folded back. FIG. 6 shows, as an example, a state where a bent piece 71 corresponding to July is bent. Thus, since the use start time can be displayed, the user can easily know the approximate replacement time of the medicine container 1 from the use start time. For example, if the expiration date of use of the medicine container 1 is 6 months, if the use start is July, it can be known that around January is the replacement time.
Note that a cut line may be employed instead of the perforation 72. Further, instead of printing, numbers or symbols may be stamped or stamped.

The indicator display unit 7 is not limited to the month display as described above, and may display a year, a day, a season, and the like according to the type of medicine to be used and the expiration date.
Further, in the above example, the bent piece 71 of the corresponding moon is bent to the back side, but it may be cut off. In this case, a perforation is provided in advance, and a cut piece having the same shape as the bent piece 71 is cut along the perforation.
As another example, instead of the bent piece 71 and the cut piece as described above, the display area for each year, month, day, or season may be recessed from the surface. In order to dent the portion corresponding to the use time in a concave shape, the paper container 11 is recessed to the back side, or the convex portion is provided on the surface of the paper container 11 in advance every year, month, day or season. It has shape | molded and you may make it indent the convex-shaped part applicable to a use time.

  Next, another embodiment of the present invention will be described with reference to FIGS. As shown in FIG. 7, the paper container 111 according to the present embodiment includes a top sheet portion 311 and a back sheet portion 312 that are continuous via a fold line A <b> 1, similarly to the paper container 11 according to the above-described embodiment. Assembled from paper sheet 310. The top sheet portion 311 has an opening window 41 and an indicator display portion 71 in addition to the hanging portion 51. The back surface sheet portion 312 has a joint portion 81 on the side portion via a folding line A2.

Both ends 312a and 312b of the back surface sheet portion 312 are formed in a concave shape that is recessed toward the center of the back surface sheet portion 312, and the tongue portions 91 and 91 protrude from the both ends 312a and 312b of the concave shape so as to be folded back.
Further, the end portion of the top sheet portion 311 opposite to the end portion where the suspending portion 51 is formed is also formed in a concave shape recessed toward the center, and the tongue portion 13 protrudes from the concave end portion so as to be folded back. ing.

  The paper sheet 310 has a drug penetration preventing layer formed on the inner surface on which the drug impregnated sheet 21 is placed. The drug-impregnated sheet 21 has a substantially rectangular shape, and both ends have a length equal to or shorter than the length between the shortest portions of the concave ends 312a and 312b.

  To assemble the paper container 111, the drug impregnated sheet 21 is placed on the inner surface of the back sheet portion 312 and then, as shown in FIG. 8, tongues 91, 91 provided at both ends 312a, 312b of the back sheet portion 312. Is folded at both ends 312a and 312b. In this state, the joining portion 81 is folded on the drug-impregnated sheet 21 at the fold line A2, and further folded at the fold line A1 between the top sheet portion 311 and the back sheet portion 312 to join the joining portion 81 to the top sheet portion 311. 9, the tongue portion 13 formed at one end (lower end) of the top sheet portion 311 is bent so as to contact the tongue portion 91 to obtain the drug container 100.

The drug container 100 obtained in this way is suspended from a clothes storage or the like using the suspension part 51. In such a suspended state, the lower end of the drug-impregnated sheet 21 is covered with the distal end portion by the tongue 91 which returns folded from the lower end of the back sheet portion 312. Therefore, the lower end of the drug-impregnated sheet 21 comes into point contact with the bottommost portion C of the concave lower end 312b formed in the back sheet portion 312 (the state shown in FIG. 9), and the drug-impregnated sheet 21 is in the back sheet portion 312. The end surface 121 of the surface sheet 311 cannot be contacted, and is separated without contacting the inner surface of the surface sheet portion 311, so that the drug impregnated sheet 21 also contacts the end surface of the opening window 41 provided in the surface sheet portion 311. It is blocked. Thereby, chemical | medical agent contamination can be reduced significantly.
Further, the tongue 91 because it is formed to be folded to the upper end of the back sheet portion 312, be placed sideways during transportation or storage of the drug container 1 00, the interior of the drug-impregnated sheet 21 is moved The medicine is prevented from entering from the end face on the upper end side.
Others are the same as the above-mentioned embodiment.

  In the above embodiment, the top sheet portion and the back sheet portion are paper sheets that are continuous via the folding line A1, but the top sheet portion and the back sheet portion are composed of separate paper sheets, and the paper container is assembled. Sometimes, both side portions of both sheet portions may be joined.

1,100 drug container 2,21 drug-impregnated sheet (drug-impregnated body)
3,310 Paper sheet 4,41 Open window 5,51 Hanging part 7,71 Indicator display part 8,81 Joint part 9,91 Tongue part 10 Protrusion part 11,111 Paper container 31,311 Top sheet part 32,312 Back sheet part

Claims (3)

A drug-impregnated body impregnated with a volatile chemical,
A drug penetration preventing layer is formed on the inner surface, containing the drug impregnated body, and a paper container having an opening window for volatilization,
The paper container is made of a paper sheet having a drug penetration preventing layer formed on the inner surface, and the paper sheet has a top sheet part and a back sheet part that are overlapped with each other while containing the drug impregnated body. And
Of the top sheet portion and the back sheet portion, at least the lower end portion of one sheet portion is formed so that a tongue protruding downward can be folded back,
The lower end of the drug-loaded member is held between at and not in contact with the end face of the paper containers located between the tongue and the top sheet portion tongue are formed or the back sheet portion folded back A drug container characterized by that. The paper container is made of a paper sheet having a drug penetration preventing layer formed on the inner surface, and the paper sheet has a top sheet part and a back sheet part that are overlapped with each other while containing the drug impregnated body, The sides of both sheet parts are joined together,
In a state where the paper container is suspended, at least the lower end portion of one of the top sheet portion and the back sheet portion is formed so that a tongue protruding downward can be folded back,
The drug impregnated body accommodated in the paper container has a protrusion at least at the lower end,
Medicament container according tongue before Symbol paper sheet, to claim 1, which is configured by folding back so as to cover at least the tip portion of the protrusion. The paper container is made of a paper sheet having a drug penetration preventing layer formed on the inner surface, and the paper sheet has a top sheet part and a back sheet part that are overlapped with each other while containing the drug impregnated body, The sides of both sheet parts are joined together,
In the state where the paper container is suspended, at least the lower end of one of the top sheet portion and the back sheet portion is formed in a concave shape recessed toward the center of the sheet portion. The tongue protrudes from the end so that it can be folded downward,
Medicament container according tongue before Symbol paper sheet, to claim 1 that is configured by folding back as overlap at least an end portion of the drug-loaded member.

Images